4-DAMP (1,1-dimethyl-4-diphenylacetoxypiperidinium iodide) is a selectivemuscarinic acetylcholine receptor (mAChR) M3antagonist.[2] It is also able to antagonize M1 receptors but has preferential activity at the M3 receptor.[3][4] It competitively binds to the acetylcholine binding site on mAChRs, causing right-ward shift in the dose response curves for mAChR agonists.
^Teixeira-Neto, FJ; McDonell, WN; Black, WD; Harris, W and; Grovum, L (2012). "Effects of muscarinic receptor antagonists on acetylcholine-induced contractions of jejunal smooth muscle in horses". Journal of Veterinary Pharmacology and Therapeutics. 35 (4): 313–318. doi:10.1111/j.1365-2885.2011.01330.x. PMID21859432.
^Greenwood, JM and; Dragunow, M (2010). "M3 muscarinic receptors promote cell survival through activation of the extracellular regulated kinase (ERK1/2) pathway". Eur J Pharmacol. 640 (1–3): 38–45. doi:10.1016/j.ejphar.2010.05.013. PMID20519144.